Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Clinical trial NCT00006025 · COMPLETED

Trial details

NCT number: NCT00006025
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2001-01-05
Primary completion: 2005-01-10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.